JP2020510691A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510691A5
JP2020510691A5 JP2019551311A JP2019551311A JP2020510691A5 JP 2020510691 A5 JP2020510691 A5 JP 2020510691A5 JP 2019551311 A JP2019551311 A JP 2019551311A JP 2019551311 A JP2019551311 A JP 2019551311A JP 2020510691 A5 JP2020510691 A5 JP 2020510691A5
Authority
JP
Japan
Prior art keywords
modified release
mpa
composition
dog
activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019551311A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020510691A (ja
JP7385474B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/022266 external-priority patent/WO2018170022A2/en
Publication of JP2020510691A publication Critical patent/JP2020510691A/ja
Publication of JP2020510691A5 publication Critical patent/JP2020510691A5/ja
Application granted granted Critical
Publication of JP7385474B2 publication Critical patent/JP7385474B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019551311A 2017-03-13 2018-03-13 非ヒト哺乳動物にミコフェノール酸活性剤を送達すための方法および組成物 Active JP7385474B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762470806P 2017-03-13 2017-03-13
US62/470,806 2017-03-13
US201762503270P 2017-05-08 2017-05-08
US62/503,270 2017-05-08
PCT/US2018/022266 WO2018170022A2 (en) 2017-03-13 2018-03-13 Methods and compositions for delivering mycophenolic acid active agents to non-human mammals

Publications (3)

Publication Number Publication Date
JP2020510691A JP2020510691A (ja) 2020-04-09
JP2020510691A5 true JP2020510691A5 (cg-RX-API-DMAC7.html) 2021-04-30
JP7385474B2 JP7385474B2 (ja) 2023-11-22

Family

ID=61911669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019551311A Active JP7385474B2 (ja) 2017-03-13 2018-03-13 非ヒト哺乳動物にミコフェノール酸活性剤を送達すための方法および組成物

Country Status (10)

Country Link
US (4) US11633378B2 (cg-RX-API-DMAC7.html)
EP (1) EP3595639A2 (cg-RX-API-DMAC7.html)
JP (1) JP7385474B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190131036A (cg-RX-API-DMAC7.html)
CN (1) CN110662533A (cg-RX-API-DMAC7.html)
AU (1) AU2018236225B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019019003A2 (cg-RX-API-DMAC7.html)
CA (1) CA3054817A1 (cg-RX-API-DMAC7.html)
MX (1) MX2019010829A (cg-RX-API-DMAC7.html)
WO (1) WO2018170022A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019010829A (es) 2017-03-13 2020-02-05 Okava Pharmaceuticals Inc Metodos y composiciones para suministrar agentes activos de acido micofenolico a mamiferos no humanos.
EP3846798A1 (en) * 2018-09-07 2021-07-14 Okava Pharmaceuticals, Inc. Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
US12701991B2 (en) 2021-08-18 2026-08-04 Texas Instruments Incorporated Integrated isolation capacitor with enhanced bottom plate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US4808413A (en) 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US5049394A (en) 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
GB0419355D0 (en) 2004-08-31 2004-09-29 Novartis Ag Organic compounds
CN1994295A (zh) 2006-01-06 2007-07-11 华北制药集团新药研究开发有限责任公司 霉酚酸盐的包有肠溶衣的药物组合物
US20100056493A1 (en) 2007-01-25 2010-03-04 Rajesh Jain Modified release pharmaceutical composition and a process of making the same
AU2008288106B2 (en) 2007-08-13 2012-03-15 Panacea Biotec Limited Extended release compositions comprising mycophenolate sodium and processes thereof
CN101969931A (zh) 2008-03-05 2011-02-09 万能药生物有限公司 包含霉酚酸的调节释放药物组合物及其方法
US20110086102A1 (en) 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
KR20110091252A (ko) * 2010-02-05 2011-08-11 서울대학교산학협력단 미코페놀레이트 모페틸을 함유한 서방성 면역 억제제
CN102793658A (zh) 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
MX2019010829A (es) 2017-03-13 2020-02-05 Okava Pharmaceuticals Inc Metodos y composiciones para suministrar agentes activos de acido micofenolico a mamiferos no humanos.

Similar Documents

Publication Publication Date Title
US8715728B2 (en) Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
KR102636273B1 (ko) 플로로글루시놀 및 트리메틸플로로글루시놀의 제약 제제
US20020132001A1 (en) Aldosterone antagonist composition for release during aldosterone acrophase
CZ20021617A3 (cs) Farmaceutický prostředek obsahující tolterodin a jeho pouľití
WO1984003440A1 (fr) Preparation a base de nifedipine a action prolongee
JP2011503017A (ja) ヒドロモルホン含有徐放性錠剤
US20210369629A1 (en) Pharmaceutical bead formulations comprising dimethyl fumarate
AU2003212491B2 (en) Colonic release composition
WO2009057138A2 (en) Controlled release pharmaceutical compositions of tolterodine
US20050175698A1 (en) Multiparticulate O-desmethylvenlafaxine salts and uses thereof
CA2967647A1 (en) Pharmaceutical bead formulations comprising dimethyl fumarate
WO2009069089A9 (en) Levetiracetam controlled release composition
US20090220593A1 (en) Extended release dosage forms of quetiapine
EP1928424A2 (en) Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
US20080081067A1 (en) Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
JP2020510691A (ja) 非ヒト哺乳動物にミコフェノール酸活性剤を送達すための方法および組成物
US20240366514A1 (en) Pharmaceutical compositions of ozanimod
EP2435082A1 (de) Transdermales therapeutisches system mit gesteuertem wirkstofffluss, das ein basisch reagierendes oxid enthält
CA1315690C (en) Synergistic combination of decarboxylase inhibitors and l-dopa pellets
WO2021126098A1 (en) Gastro-resistant pellet comprising duloxetine
OA22166A (en) Modified-Release Silodosin Compositions And Use Thereof In Methods For Male Contraception.
WO2026084757A1 (en) Pharmaceutical formulations comprising naltrexone and bupropion
US20060173081A1 (en) Treating morning migraines with propranolol
EP4622633A1 (en) Modified-release silodosin compositions and use thereof in methods for male contraception
ZA200407595B (en) Oral suspension of amoxicillin capsules